243 related articles for article (PubMed ID: 21156214)
21. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
[TBL] [Abstract][Full Text] [Related]
22. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
[TBL] [Abstract][Full Text] [Related]
23. Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes.
Hua Y; Xue J; Sun F; Zhu L; Xie M
Pharmacology; 2009; 83(1):18-25. PubMed ID: 18971601
[TBL] [Abstract][Full Text] [Related]
24. [Regulatory effects of inhaled steroids on expression of matrix metalloproteinase-9 and its inhibitor in asthmatic rats].
Qiao HM; Lu JR; Cheng HJ; Liu L; Ma QS; Fu WY; Zhao FX
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):591-4. PubMed ID: 16191269
[TBL] [Abstract][Full Text] [Related]
25. Dynamic changes in matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 levels during wound healing in diabetic rats.
Yang C; Zhu P; Yan L; Chen L; Meng R; Lao G
J Am Podiatr Med Assoc; 2009; 99(6):489-96. PubMed ID: 19917734
[TBL] [Abstract][Full Text] [Related]
26. The expression of metalloproteinase-2, -9, and -14 and of tissue inhibitors-1 and -2 is developmentally modulated during osteogenesis in vitro, the mature osteoblastic phenotype expressing metalloproteinase-14.
Filanti C; Dickson GR; Di Martino D; Ulivi V; Sanguineti C; Romano P; Palermo C; Manduca P
J Bone Miner Res; 2000 Nov; 15(11):2154-68. PubMed ID: 11092396
[TBL] [Abstract][Full Text] [Related]
27. Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo.
Chase AJ; Bond M; Crook MF; Newby AC
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):765-71. PubMed ID: 12006388
[TBL] [Abstract][Full Text] [Related]
28. Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats.
Wang Y; Huang G; Mo B; Wang C
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323108
[TBL] [Abstract][Full Text] [Related]
29. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
Peterson JT; Li H; Dillon L; Bryant JW
Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
[TBL] [Abstract][Full Text] [Related]
30. Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus.
Zechel J; Gohil H; Lust WD; Cohen A
J Neurosci Res; 2002 Sep; 69(5):662-8. PubMed ID: 12210832
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium.
Kiczak L; Tomaszek A; Bania J; Paslawska U; Zacharski M; Janiszewski A; Rybinska I; Dziegiel P; von Haehling S; Ardehali H; Jankowska EA; Ponikowski P
J Physiol Pharmacol; 2014 Jun; 65(3):365-75. PubMed ID: 24930508
[TBL] [Abstract][Full Text] [Related]
32. Anti-inflammatory Property of β-D-Mannuronic Acid (M2000) on Expression and Activity of Matrix Metalloproteinase-2 and -9 through CD147 Molecule in Phorbol Myristate Acetate-differentiated THP-1 Cells.
M Farahani M; Motevaseli E; Maghsood F; Heidari-Kharaji M; Mirshafiey A
Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):443-451. PubMed ID: 29149784
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular drugs inhibit MMP-9 activity from human THP-1 macrophages.
Rival Y; Benéteau N; Chapuis V; Taillandier T; Lestienne F; Dupont-Passelaigue E; Patoiseau JF; Colpaert FC; Junquéro D
DNA Cell Biol; 2004 May; 23(5):283-92. PubMed ID: 15169608
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization.
Ma DH; Chen JK; Kim WS; Hao YX; Wu HC; Tsai RJ; Hwang DG; Zhang F
Ophthalmic Res; 2001; 33(6):353-62. PubMed ID: 11721189
[TBL] [Abstract][Full Text] [Related]
35. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
[TBL] [Abstract][Full Text] [Related]
36. Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB.
Bu DX; Hemdahl AL; Gabrielsen A; Fuxe J; Zhu C; Eriksson P; Yan ZQ
Am J Pathol; 2006 Dec; 169(6):2245-53. PubMed ID: 17148685
[TBL] [Abstract][Full Text] [Related]
37. Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.
Chen J; Ren Z; Zhu M; Khalil RA
Biochem Pharmacol; 2017 Aug; 138():81-95. PubMed ID: 28506758
[TBL] [Abstract][Full Text] [Related]
38. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
Ding HL; Guo Y; Xu MT; Li HY; Fu ZZ
Chin Med J (Engl); 2007 Nov; 120(21):1886-9. PubMed ID: 18067760
[TBL] [Abstract][Full Text] [Related]
39. Increased matrix metalloproteinase 9 activity and mRNA expression in lung ischemia-reperfusion injury.
Yano M; Omoto Y; Yamakawa Y; Nakashima Y; Kiriyama M; Saito Y; Fujii Y
J Heart Lung Transplant; 2001 Jun; 20(6):679-86. PubMed ID: 11404174
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide-mediated regulation of β-amyloid clearance via alterations of MMP-9/TIMP-1.
Ridnour LA; Dhanapal S; Hoos M; Wilson J; Lee J; Cheng RY; Brueggemann EE; Hines HB; Wilcock DM; Vitek MP; Wink DA; Colton CA
J Neurochem; 2012 Dec; 123(5):736-49. PubMed ID: 23016931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
